For the first time in history, Medicare has the power to negotiate the price it pays for some of the costliest and most-used ...

President Donald Trump incorrectly placed the blame for high prescription drug prices in the U.S. on foreign nations, making ...

Toward the end of his first Administration, Trump signed a similar Executive Order aimed at lowering the prices of some drugs ...

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...

The Centers for Medicare & Medicaid Services May 12 released draft guidance for the third round of negotiations for the Medicare Drug Price Negotiation Program. The guidance includes policies ...

In signing an executive order aimed at reducing U.S. drug prices, President Donald Trump said some prices would be cut in ...

President Donald Trump has now been in office for more than 100 days, and investors certainly have a much more clear picture ...

The president has signed an executive order stating that the US will institute a “most-favored-nation” policy, whereby the US will pay the same price for a drug as the nation that pays the lowest ...

To be clear, that concern was well-founded: High drug prices are one reason the U.S. has become a global leader in medical innovation. Some of the most important advancements in the field — from ...

President Donald Trump signed an Executive Order (EO) titled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients” aimed ...

Congressional Democrats who praised former President Joe Biden’s executive actions against America’s pharmaceutical industry are holding their praise for President Trump’s latest executive order.

The Trump Administration recently signed an executive order that calls for most-favored-nation prices on brand-name drugs. Branded drug prices in the U.S. can be several times higher than prices ...